-
2022 wrapped: Celebrating 10 years at Nicoya
We took a moment to look back on the key events that shaped this milestone year. By Ryan Denomme, Co-Founder and CEO Quick links A year of milestones What’s new for our users? Learnings from the fie...
-
SPR vs BLI: Comparing label-free tools for Fc receptor characterization
Alto™ streamlines the characterization of Fc gamma receptors in our latest app note comparing analysis with Digital SPR and BLI. Fc receptors (FcR), named for their binding specificity to the fragme...
-
New Nature study reveals insights into de novo autoreactivity in severe COVID-19 using Alto™ Digital SPR
Kinetic analysis of de novo autoreactivity in severe COVID-19 reveals important implications for early intervention and treatment in patients with post-COVID sequelae. The SARS-CoV-2 outbreak was firs...
-
Targeting interleukins: How digital SPR accelerates monoclonal antibodies for immune-related diseases
Alto’s unmatched ability to seamlessly characterize mAbs make it the optimal fit for biologics developers. Read our latest application note on digital SPR analysis of the interleukin-6 receptor (IL-...